Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...

This first-in-class ASO replicates the protective effects of naturally occurring CD33 loss-of-function variants, which are associated with increased resilience to neurodegenerative disease, reduced ...

The small interfering RNA (siRNA) therapy, designed to reduce triglyceride levels by suppressing production of apolipoprotein ...

As the biopharma world predominantly zeroes in on late-stage assets, Eli Lilly is prioritizing early science with the opening ...

Hire today released its 7th Annual Talent Retention Report, revealing that voluntary quits declined for the second consecutive year. However, employees are staying put ? or job hugging ? not ...

Trianz, a Transformation Services as Software company that accelerates customer business transformations with cloud, data, applications and AI capabilities, announced a major strategic validation from ...